# Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/role-of-anlotinib-induced-ccl2-decrease-in-anti-angiogenesis-and-response/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jun Lü,Hua Zhong,Tianqing Chu,Xueyan Zhang,Rong Li,Jiayuan Sun,Runbo Zhong,Yuqin Yang,Mohammad Shah Alam,Yuqing Lou,Jianlin Xu,Yanwei Zhang,Jun Wu,Xiaowei Li,Xiaodong Zhao,Kai Li,Liming Lu,Baohui Han |
| Citations | 101 |
| DOI | 10.1183/13993003.01562-2018 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2905647095 |
| PMID | 30578392 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Jun Lü](https://scholariq.org/researchers/jun-lu/)
- [Jianlin Xu](https://scholariq.org/researchers/jianlin-xu/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.